Glenn Goddard, EVP, Chief Financial Officer at Intellia Therapeutics, Inc. (NTLA), sold 2,026 shares at $112.24 ($227K) on 2022-01-01, disclosed to the SEC on 2022-03-03.
Open-market sale of $227k NTLA by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $112.24 | 1,013 | $114K | 50.0% |
| 2 | $112.24 | 1,013 | $114K | 50.0% |
| Total | $112.24 avg | 2,026 | $227K | 100% |
| Filing → |
| NTLA | SELL | 2021-09-09 | $1.3M | — | Filing → |
| NTLA | SELL | 2021-09-01 | $5.0M | — | Filing → |
| NTLA | SELL | 2021-08-06 | $6.0M | — | Filing → |